Company
Sarepta Therapeutics, Inc.
SRPT · CIK 0000873303
Disposition (code F) of 21,423 shares at $22.22 per share.
Reporting Person Rodino-Klapac Louise · Officer Title President, R&D and Tech Ops · Transaction Code F
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001193125-26-385536 · filed 2026-09-08 · View filing →
Disposition (code F) of 22,025 shares at $22.22 per share.
Reporting Person Rothfuss Cristin · Officer Title EVP, General Counsel · Transaction Code F
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001193125-26-385541 · filed 2026-09-08 · View filing →
Disposition (code F) of 24,799 shares at $22.22 per share.
Reporting Person Estepan Ian Michael · Officer Title Chief Operating Officer · Transaction Code F
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001193125-26-385544 · filed 2026-09-08 · View filing →
Disposition (code F) of 13,272 shares at $22.22 per share.
Reporting Person Wong Ryan Ho-Yan · Officer Title Chief Financial Officer · Transaction Code F
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001193125-26-385545 · filed 2026-09-08 · View filing →